Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

Abstract Background Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed intervals between primary debulking surgery and adjuvant chemotherapy wa...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Soo Young Jeong, Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae, Yoo-Young Lee
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2019-12-01
Ráidu:	Journal of Ovarian Research
Fáttát:	Secondary cytoreductive surgery Adjuvant chemotherapy Treatment interval Recurrent epithelial ovarian cancer
Liŋkkat:	https://doi.org/10.1186/s13048-019-0602-5
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!